Elaprase

Elaprase Patient Counseling Information

idursulfase

Manufacturer:

Genzyme

Distributor:

DKSH
Full Prescribing Info
Patient Counseling Information
Information for Patients: Patients should be advised that life-threatening anaphylactic reactions have occurred in some patients during and up to 24 hours after ELAPRASE therapy. Patients who have experienced anaphylactic reactions may require prolonged observation. Patients with compromised respiratory function or acute respiratory disease may be at risk of serious acute exacerbation of their respiratory compromise due to hypersensitivity reactions.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in